Sign in

What researchers published on Idiopathic pulmonary fibrosis

10,460 papers, newest first.

Showing 100 of 10,460

  • Long-Term Prognosis and Transition Period until Progression in Fibrotic Hypersensitivity Pneumonitis.Respiration; international review of thoracic diseases
  • ReviewStem cell-derived EVs in the treatment of pulmonary fibrosis: from mechanistic insights to clinical-grade manufacturing and nebulized delivery.Expert review of respiratory medicine
  • Indoor Air Quality Management for Patients with COPD and IPF: Practical Recommendations Based on Current Standards and Evidence.Tuberculosis and respiratory diseases
  • A Mucin-5B variant associated with idiopathic pulmonary fibrosis may prolong survival in the general population.The Journal of clinical investigation
  • Association of idiopathic pulmonary fibrosis with TG/HDL-C and TC/HDL-C: a retrospective cohort study.BMC pulmonary medicine
  • LitGene: an interpretable transformer model integrating text and ontology for gene representation learning.Nature communications
  • A multi-targeted, barrier-penetrating inhalable nanoplatform for simultaneous immunomodulation and antifibrotic therapy in idiopathic pulmonary fibrosis.Materials today. Bio
  • ReviewDifferentiation arrest of transitional alveolar epithelial cells drives pulmonary fibrosis.Cell communication and signaling : CCS
  • Alive and on Initial Antifibrotic Treatment: Real-World Treatment Durability in Idiopathic and Progressive Pulmonary Fibrosis.Journal of clinical medicine
  • ReviewPulmonary Fibroblast Heterogeneity and Functional Remodeling in Idiopathic Pulmonary Fibrosis: State Persistence and Reversibility.International journal of molecular sciences
  • Vitamin K3 (Menadione) Targets TBK1 to Enhance the Efficacy of Pirfenidone in a Mouse Model of Bleomycin-Induced Pulmonary Fibrosis.International journal of molecular sciences
  • ReviewPCSK6 in Pathophysiology and Its Potential Involvement in Pulmonary Fibrosis.Molecules (Basel, Switzerland)
  • Single-Cell Transcriptomic Analysis Identifies a Translation/RBP-Related Fibroblast Signature for Drug Repurposing in Idiopathic Pulmonary Fibrosis.International journal of molecular sciences
  • Quality of Spirometry Maneuvers in Interstitial Lung Disease Patients in a Tertiary Facility.Journal of clinical medicine
  • ReviewSelective Immune Clearance and Lung Repair in Pulmonary Fibrosis.Biology
  • The role of 18F-FDG PET-CT in predicting progressive pulmonary fibrosis in idiopathic inflammatory myopathy associated interstitial lung disease.Frontiers in immunology
  • ReviewIdiopathic pulmonary fibrosis: Five trials to watch.Med (New York, N.Y.)
  • The Burden of Chronic Cough in Patients With Interstitial Lung Disease: a US Survey-Based Analysis of Its Effects on Daily Life and Emotional and Social Well-Being.Chest
  • Transcriptomic Signature-Guided EGFP Labeling of Alveolar Epithelial Cells via RNA Sensing in Mouse Lungs In Vivo and Human Idiopathic Pulmonary Fibrosis Lung Slices Ex Vivo.Bio-protocol
  • Lung-Tailored Pyrrolo-pyrimidine DDR Inhibitors Designed for Optimized Local Delivery.Journal of medicinal chemistry
  • ReviewObstructive Sleep Apnea, Ferroptosis, and Idiopathic Pulmonary Fibrosis: A Potential Second-Hit Mechanism Linking Intermittent Hypoxia to Fibrotic Progression.Respiratory medicine
  • Integrated Multi-Omics Identifies SLIT2 as a Regulator of Senescence-Associated Fibroblast Remodeling in Idiopathic Pulmonary Fibrosis.Inflammation
  • Discovery of YKS-34, a Highly Selective PDE4B Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis.Journal of medicinal chemistry
  • Meta-analysisEffects of different durations of exercise-based pulmonary rehabilitation intervention in patients with idiopathic pulmonary fibrosis: A systematic review and meta-analysis.Medicine
  • ReviewInhalable nanodelivery strategies for overcoming the pathological cascade of idiopathic pulmonary fibrosis.International journal of pharmaceutics
  • RNA-binding proteins as emerging regulators in interstitial lung diseases.American journal of respiratory cell and molecular biology
  • Extracellular vesicles presenting "don't eat me" signal limit the efferocytic capacity in lung fibrosis.Proceedings of the National Academy of Sciences of the United States of America
  • Selective ORgan-targeting lipid nanoparticles deliver SMAD7 mRNA to fibrotic lungs and attenuate pulmonary fibrosis.Journal of controlled release : official journal of the Controlled Release Society
  • Time is lung? Quantitative CT and earlier detection of progressive pulmonary fibrosis.Annals of the American Thoracic Society
  • Tacrolimus ameliorates pulmonary hypertension associated with pulmonary fibrosis via modulation of vascular remodeling.Frontiers in pharmacology
  • ReviewLactate-associated fibroblast-macrophage signaling in idiopathic pulmonary fibrosis: evidence boundaries and immunopharmacological opportunities.Frontiers in pharmacology
  • Clinical and prognostic characteristics of concurrent small cell lung cancer in patients with idiopathic pulmonary fibrosis: a retrospective study.Journal of thoracic disease
  • ReviewHypersensitivity Pneumonitis: Clinical Paradigm Evolution, Immune-Driven Mechanisms, and Fibrotic Progression.Journal of immunology research
  • Jinshui Huanxian Formula Combined with Exercise Rehabilitation Improves Skeletal Muscle Mitochondrial Damage in Treatment of Pulmonary Fibrosis by AMPK/mTOR/HIF-1 Pathway.Chinese journal of integrative medicine
  • Weight Loss, FVC Decline, and Composite Physiologic Index as Complementary Prognostic Indicators in Idiopathic Pulmonary Fibrosis over the Disease Course: Time-Updated and Landmark Analysis.Archivos de bronconeumologia
  • Large-scale plasma proteomics identifies proteins and pathways associated with incident interstitial lung disease.Frontiers in immunology
  • CXCL12: a key gene in IPF-COPD pathogenesis and its therapeutic potential.Journal of translational medicine
  • Discovering Biomarkers for Idiopathic Pulmonary Fibrosis by Correlating Serum Extracellular Vesicle Proteins With Clinical Data.Proteomics. Clinical applications
  • Alveolar Type II Cell-derived MMP1high basal cells promote destructive microcysts in idiopathic pulmonary fibrosis.JCI insight
  • Integrating multi-omics and machine learning to reveal IL1R2-driven macrophage-fibroblast spatial interactions in polycyclic aromatic hydrocarbon-induced pulmonary fibrosis.Frontiers in immunology
  • Lifetime Endogenous Estrogen Exposure Predicts Idiopathic Pulmonary Fibrosis Risk in Postmenopausal Women Based on a Nationwide Population Study.Journal of Korean medical science
  • Tocilizumab in refractory anti-synthetase syndrome-associated interstitial lung disease:a phenotype-stratified cohort study.Respiratory research
  • Macrophage-targeted GAS6 siRNA delivery by a multifunctional mannan-peptide nanocarrier attenuates pulmonary fibrosis progression.Journal of controlled release : official journal of the Controlled Release Society
  • [Unfavorable prognosis of pathogenic variants in the telomerase complex in cases of familial pulmonary fibrosis].Revue des maladies respiratoires
  • Exogenous tryptophan aggravates experimental lung fibrosis through activation of AKT-mTORC1 pathway.PloS one
  • Progressive pulmonary fibrosis in fibrotic interstitial lung disease: a Danish cohort study.ERJ open research
  • Local and systemic SP-D in IPF and SARD-ILD.BMC pulmonary medicine
  • ReviewCombined Pulmonary Fibrosis and Emphysema: Current Status and Future Perspective.The clinical respiratory journal
  • 6-min walk test reveals early physiological impairment in fibrotic interstitial lung diseases.ERJ open research
  • Integrative Multi-omics and machine learning analysis of sphingolipid-associated molecular stratification identifies diagnostic and prognostic signatures in idiopathic pulmonary fibrosis.Orphanet journal of rare diseases
  • A plain language review of the TETON-1 and TETON-2 studies: inhaled treprostinil (Tyvaso) in idiopathic pulmonary fibrosis.Expert review of respiratory medicine
  • Deep learning-based quantification of CT changes after 1 year of pirfenidone treatment as a prognostic marker in idiopathic pulmonary fibrosis.Insights into imaging
  • Review[The role of immune checkpoints in idiopathic pulmonary fibrosis: An emerging therapeutic paradigm].Revue des maladies respiratoires
  • Integrative network toxicology and machine learning reveal the potential role of 5-hydroxymethylfurfural in exacerbating pulmonary fibrosis.PloS one
  • The prognostic value of erythrocyte sedimentation rate in all-cause mortality of patients with idiopathic pulmonary fibrosis: Based on inpatient hospital records.Therapeutic advances in respiratory disease
  • ReviewTreprostinil: Mechanism of Action, Clinical, and Translational Science.Clinical and translational science
  • Effectiveness of home-based pulmonary rehabilitation in patients with interstitial lung disease: a systematic review and meta-analysis.BMJ open respiratory research
  • Targeting ACKR1+ Endothelial Cells Attenuates Pulmonary Fibrosis by Halting Monocytes Infiltration/Polarization and Endothelial-to-Mesenchymal Transition.Pharmacological research
  • ReviewPathological regulatory roles of lysine acylation modifications in idiopathic pulmonary fibrosis (Review).Molecular medicine reports
  • Integrative network toxicology and pharmacology reveal that kaempferol alleviates BaP-triggered pulmonary fibrosis via suppressing Ras/COX-2-dependent cellular senescence.Frontiers in pharmacology
  • Soluble macrophage-mannose receptor, CD206 (sCD206): A new potential biomarker for idiopathic pulmonary fibrosis.Immunobiology
  • Serum KL-6 Levels at Acute Exacerbation in Patients With Interstitial Lung Disease.In vivo (Athens, Greece)
  • Metabolomic Profiles Predict the Risk of Idiopathic Pulmonary Fibrosis.Phenomics (Cham, Switzerland)
  • ReviewCardiovascular complications in idiopathic pulmonary fibrosis and the emerging concept of the heart-lung fibrotic axis: a narrative review.Frontiers in medicine
  • IPF-RAG: temporal-aware retrieval-augmented generation for idiopathic pulmonary fibrosis care.Frontiers in digital health
  • Survival and immunomodulatory therapy in autoimmune disease-associated progressive pulmonary fibrosis: a multicenter registry (NEREA).Rheumatology (Oxford, England)
  • Tectochrysin alleviates idiopathic pulmonary fibrosis via inhibiting PI3K/AKT/mTOR signaling pathway by targeting PI3K p85.Pulmonary pharmacology & therapeutics
  • Distinct BAL cytokine signatures define immunopathological endotypes in interstitial lung disease.Frontiers in physiology
  • PRDM16 attenuates pulmonary fibrosis through NuRD-mediated epigenetic remodeling in lung fibroblasts.Science China. Life sciences
  • Real-World Management and Outcomes of Probable and Indeterminate UIP Patterns on HRCT: A Retrospective Cohort Study and Implications for the 2022 IPF Guideline.Journal of clinical medicine
  • Association of the Charlson Comorbidity Index and Age-Adjusted Charlson Comorbidity Index with Clinical Course and Mortality in Patients with Idiopathic Pulmonary Fibrosis.Biomedicines
  • The Impact of Idiopathic Pulmonary Fibrosis on the Incidence and Severity of Radiation Pneumonitis in Non-Small Cell Lung Cancer Patients Following Radiotherapy.Biomedicines
  • ReviewUpdates on the Translational Value of Idiopathic Pulmonary Fibrosis Models Across Species: Deeper Insights Through Comparative Pathology.Biomolecules
  • ReviewThe Shared Pathological Niche in Pulmonary Fibrosis: From Aberrant Epithelial Repair to ECM Remodeling.Biomedicines
  • Prevalence and prognostic significance of obstructive sleep apnea in patients with idiopathic pulmonary fibrosis: A prospective cohort study.Annals of thoracic medicine
  • Shared Enrichment of the MUC5B Variant rs35705950 in Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis: Evidence from a Russian Cohort.Diagnostics (Basel, Switzerland)
  • Meta-analysisPerioperative Antifibrotic Treatment and Early Postoperative Outcomes in Patients With Idiopathic Pulmonary Fibrosis Undergoing Lung Cancer Surgery: A Systematic Review and Meta-Analysis.Thoracic cancer
  • Meta-analysisEfficacy and Safety of Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.Advances in respiratory medicine
  • Correction: Comprehensive analysis of neutrophil extracellular traps-associated inflammatory genes for patients with idiopathic pulmonary fibrosis.Molecular genetics and genomics : MGG
  • Hyperpolarized 129Xe MRI membrane uptake associates with lung function changes in patients with idiopathic pulmonary fibrosis initiating antifibrotic therapy.American journal of respiratory and critical care medicine
  • TOMM5-glycolysis-Mlxipl axis: A novel mechanistic insight into idiopathic pulmonary fibrosis.Biochimica et biophysica acta. Molecular basis of disease
  • Emergency granulopoiesis is associated with intermittent hypoxemia in idiopathic pulmonary fibrosis.American journal of respiratory and critical care medicine
  • Bridging the GAP: Prognostic stratification by longitudinal FVC changes in IPF.Journal of the Chinese Medical Association : JCMA
  • ReviewThe Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio for Mortality in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.Cureus
  • ReviewTherapeutic advances in pulmonary fibrosis.Therapeutic advances in respiratory disease
  • Nailfold videocapillaroscopy as a diagnostic clue in interstitial lung disease: differentiating idiopathic from autoimmune patterns in a Caucasian cohort.Reumatismo
  • PreprintSobetirome, a thyroid hormone receptor beta agonist, is a potential therapeutic agent for pulmonary fibrosis.bioRxiv : the preprint server for biology
  • Effect of exportin-1 inhibitors on profibrotic responses in human lung fibroblasts.Biochemical and biophysical research communications
  • Institutional patterns in diagnosis and antifibrotic-era treatment uptake for IPF and PPF across U.S. centers.PloS one
  • Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variants.The European respiratory journal
  • Predicting progressive pulmonary fibrosis in idiopathic inflammatory myopathy-associated interstitial lung disease: A machine learning approach integrating quantitative CT and clinical features.Respiratory medicine
  • Lung Transplantation for Interstitial Lung Disease: A Northern Ireland Cohort Study.Pulmonary therapy
  • Pulmonary diffusion capacity to select patients for echocardiographic evaluation of pulmonary hypertension in interstitial lung disease: Impact of interstitial lung disease phenotype.Respiratory investigation
  • ReviewSpatiotemporal Immune-Fibroblast Crosstalk in Pulmonary Fibrosis: From Failed Repair to Fibrotic Niche Formation.International journal of biological sciences
  • Observational studyInterstitial Lung Diseases treatment prescription practices among pulmonologists in India: A prospective multicentre observational study (India-ILD care study).PloS one
  • ReviewA narrative review of stem cell-based therapy for fibrosing interstitial lung diseases: clinical evidence and translational perspectives.Frontiers in pharmacology
  • Ism1 deficiency in mice exacerbates bleomycin-induced pulmonary fibrosis with enhanced cellular senescence and delayed fibrosis resolution.hLife
  • Case reportNerandomilast treatment improves a case of progressive pulmonary fibrosis combined with severe plaque psoriasis: A case report from a clinical trial.Therapeutic advances in respiratory disease
  • Systematic reviewPhase 3 Antifibrotic-Directed Therapy Outcomes in Idiopathic Pulmonary Fibrosis: Beyond FVC Decline.Lung
  • Cellular Senescence Dysregulates Antiviral Interferon Responses in Idiopathic Pulmonary Fibrosis.Aging cell